Replies to post #68631 on Ayala Pharmaceuticals Inc (fka ADXS)

[blueyedcatch]

It`s a fair point and that`s why I hope we get that deal with Merck Asap. It`s ready to move forward,and Merck`s gonna have to pay if they want that,,no ands ifs or buts. I sure hope you don`t think we should pay for the phase 3 trial with Merck,cause we`re not going to. In the beginning I was all for keeping all the rights for everything,but in hindsight I truly believe that if we had sold off a few like Adro,we`d be fine right now,cash wise,and there`s only so much the company can put on shareholders back,to pay for.Maybe we`ll get the hold lifted for us this week or next,and then we`ll start the NEO,and get some Dough re me from Amgn for it,then we`ll secure a deal with MErck,with upfront cash,and we wait for the EMA and Axal. Once we get close to approval,it`ll be between Merck and Amgn,who`ll try and buy us,and we`ll have most of our rights. Amgn will have NEO and Merck will have the PSA with us. Were you screaming like me,that the NEO should`nt have been given away,because that was a doozy of a give away for our licensing rights.

[ignatiusrielly35]

Right on, Gantor. Doc’s strategy of retaining rights may have been viable at one point. But he failed to recognize that it became unviable due to the relentless attack on the pps. So in a real sense, although he left us vulnerable to manipulation, the manipulation caused the current predicament. If we were at a fair valuation, suddenly ADXS is in a completely different environment. Really the only problem ADXS faces currently is access to capital. Everything else looks very good.